Cargando…
Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
Novel oral anticoagulants (NOACs) are no longer “novel” but their reversal agents definitely are. Although NOACs enjoy high clinical efficacy, monitoring and reversal of their effect is a challenge which this review attempts to surmount. Ideally, for NOAC activity measurement, specific anti-Factor I...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423941/ https://www.ncbi.nlm.nih.gov/pubmed/30988530 http://dx.doi.org/10.4103/ija.IJA_734_18 |